BR0007490A - Derivados de morfolina hipolipidêmica e antioxidante - Google Patents
Derivados de morfolina hipolipidêmica e antioxidanteInfo
- Publication number
- BR0007490A BR0007490A BR0007490-0A BR0007490A BR0007490A BR 0007490 A BR0007490 A BR 0007490A BR 0007490 A BR0007490 A BR 0007490A BR 0007490 A BR0007490 A BR 0007490A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- derivatives
- ono
- compounds
- formula
- Prior art date
Links
- 230000003078 antioxidant effect Effects 0.000 title abstract 4
- 239000003963 antioxidant agent Substances 0.000 title abstract 3
- 230000000055 hyoplipidemic effect Effects 0.000 title abstract 3
- 150000002780 morpholines Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 abstract 3
- 238000006243 chemical reaction Methods 0.000 abstract 3
- 238000010992 reflux Methods 0.000 abstract 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 abstract 2
- RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 abstract 1
- -1 3-bromopropoxy Chemical group 0.000 abstract 1
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 238000008214 LDL Cholesterol Methods 0.000 abstract 1
- 150000001414 amino alcohols Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 229940125904 compound 1 Drugs 0.000 abstract 1
- 229940125773 compound 10 Drugs 0.000 abstract 1
- 229940125782 compound 2 Drugs 0.000 abstract 1
- 229940126214 compound 3 Drugs 0.000 abstract 1
- 229940125898 compound 5 Drugs 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 230000000871 hypocholesterolemic effect Effects 0.000 abstract 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 abstract 1
- SYNLPOQKBSLESU-UHFFFAOYSA-N morpholin-2-ol Chemical compound OC1CNCCO1 SYNLPOQKBSLESU-UHFFFAOYSA-N 0.000 abstract 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 229910001961 silver nitrate Inorganic materials 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR99100015 | 1999-01-14 | ||
| GR99100227 | 1999-07-05 | ||
| PCT/GR2000/000003 WO2000042030A1 (en) | 1999-01-14 | 2000-01-14 | Hypolipidemic and antioxidant morpholine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0007490A true BR0007490A (pt) | 2001-10-16 |
Family
ID=26316685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0007490-0A BR0007490A (pt) | 1999-01-14 | 2000-01-14 | Derivados de morfolina hipolipidêmica e antioxidante |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6693192B1 (https=) |
| EP (1) | EP1140877A1 (https=) |
| JP (1) | JP2002534516A (https=) |
| CN (1) | CN1336922A (https=) |
| AU (1) | AU770267B2 (https=) |
| BR (1) | BR0007490A (https=) |
| CA (1) | CA2359476C (https=) |
| WO (1) | WO2000042030A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005016402D1 (de) | 2004-05-24 | 2009-10-15 | Genvault Corp | Stabile lagerung von protein und stabile lagerung von nukleinsäure in wiedergewinnbarer form |
| WO2010031007A2 (en) | 2008-09-12 | 2010-03-18 | Genvault Corporation | Matrices and media for storage and stabilization of biomolecules |
| EP2419400A1 (en) | 2009-04-15 | 2012-02-22 | Research Triangle Institute | Monoamine reuptake inhibitors |
| CA2800219C (en) | 2010-05-21 | 2019-03-12 | Research Triangle Institute | 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence |
| JP2013526583A (ja) | 2010-05-21 | 2013-06-24 | リサーチ・トライアングル・インスティチュート | フェニルモルホリンおよびその類似体 |
| GR20100100333A (el) * | 2010-06-10 | 2012-01-31 | Αγγελικη Παναγιωτη Κουρουνακη | Μορφολινικα παραγωγα υποκατεστημενων διαφαινυλικων ενωσεων |
| CN102127031B (zh) * | 2011-01-17 | 2012-10-17 | 江苏江神药物化学有限公司 | 一种麻黄碱类化合物季胺盐及其合成方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3717560A1 (de) * | 1987-05-25 | 1988-12-08 | Thomae Gmbh Dr K | Neue 2-hydroxy-morpholine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
-
2000
- 2000-01-14 JP JP2000593598A patent/JP2002534516A/ja active Pending
- 2000-01-14 EP EP00900299A patent/EP1140877A1/en not_active Withdrawn
- 2000-01-14 US US09/869,881 patent/US6693192B1/en not_active Expired - Fee Related
- 2000-01-14 CA CA002359476A patent/CA2359476C/en not_active Expired - Fee Related
- 2000-01-14 BR BR0007490-0A patent/BR0007490A/pt not_active Application Discontinuation
- 2000-01-14 CN CN00802766A patent/CN1336922A/zh active Pending
- 2000-01-14 WO PCT/GR2000/000003 patent/WO2000042030A1/en not_active Ceased
- 2000-01-14 AU AU19960/00A patent/AU770267B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU1996000A (en) | 2000-08-01 |
| EP1140877A1 (en) | 2001-10-10 |
| CN1336922A (zh) | 2002-02-20 |
| US6693192B1 (en) | 2004-02-17 |
| JP2002534516A (ja) | 2002-10-15 |
| CA2359476A1 (en) | 2000-07-20 |
| CA2359476C (en) | 2006-01-03 |
| WO2000042030A1 (en) | 2000-07-20 |
| AU770267B2 (en) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1169059A (en) | Dibenz¬b,f|¬1,4|oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same | |
| DK1041068T3 (da) | Compounds for treating and preventing diabetic complications | |
| BR0206433A (pt) | Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto | |
| EA200100933A1 (ru) | Аминопиримидины в качестве ингибиторов сорбитолдегидрогеназы | |
| BR9910326A (pt) | Processo para preeparar isoxazóis, composto, processo para preparar compostos, uso de compostos, e, processo para preparar tioéteres | |
| DK14892D0 (da) | Tigogenin-cellobiosid-heptaacetat forbindelser og fremgangsmaade til fremstilling heraf | |
| ES2036562T3 (es) | Un procedimiento para produccion de un derivado de pirrolidinamida. | |
| Hoefle et al. | Cardioselective. Beta.-adrenergic blocking agents. 1. 1-[(3, 4-dimethoxyphenethyl) amino]-3-aryloxy-2-propanols | |
| ES8304097A1 (es) | Un procedimiento para la obtencion de un compuesto de 4(3h- quinazolinona). | |
| BR0007490A (pt) | Derivados de morfolina hipolipidêmica e antioxidante | |
| FI86175B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenolderivat. | |
| NO971384L (no) | Pyrimidinylpyrazol-derivat | |
| DK0895981T3 (da) | Nye terphenylforbindelser og medikamenter indeholdende disse forbindelser | |
| BR9911250A (pt) | Processo para preparação de compostos | |
| JPS5587784A (en) | Manufacture of alphaatocopherol | |
| ES434446A1 (es) | Procedimiento para la preparacion de derivados de acidos fenoxialcohilcarboxilicos. | |
| Foye et al. | Antiradiation compounds. 20. 1-Methylquinolinium (and pyridinium)-2-dithioacetic acid derivatives | |
| ATE226585T1 (de) | Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen | |
| ES1027323U (es) | Ventilador radial | |
| ES2012695A6 (es) | Un procedimiento para la preparacion de 4-(6'-metoxi -2'- naftil)-but-3-en -2-ona. | |
| DK0963998T3 (da) | Azasteroidforbindelse til behandling eller prævention af prostatacancer | |
| BR0006978A (pt) | Processo para preparação de 1,5-diaril-3-pirazóis substituìdos | |
| HAYASHI et al. | Studies on antitumor substances. XII. Synthesis of bis (2, 3-epoxypropyl) amine derivatives and the reaction with some nucleophiles | |
| BR0203426A (pt) | Processo para preparação dos compostos 2-(4-alquil-1-piperazinil)-benzaldeìdo e -benzilidenila | |
| ES8604220A1 (es) | Un procedimiento para preparar derivados de pirimidoisoqui- nolina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O,13 E 25 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |